N
EXAS

Nuveen’s Exact Sciences EXAS Stock Holding History

Nuveen’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-813,252
Closed -$82.6M – 3251
2025
Q4 		$82.6M Sell
813,252
-246,420
-23% -$19.8M 0.02% 457
2025
Q3 		$58M Buy
1,059,672
+242,523
+30% +$12.1M 0.02% 562
2025
Q2 		$43.4M Sell
817,149
-230,067
-22% -$11.7M 0.01% 668
2025
Q1 		$45.3M Sell
1,047,216
-177,349
-14% -$8.98M 0.01% 663
2024
Q4 		$68.8M Buy
1,224,565
+238,931
+24% +$14.9M 0.02% 519
2024
Q3 		$67.1M Buy
985,634
+80,979
+9% +$4.57M 0.02% 532
2024
Q2 		$38.2M Sell
904,655
-21,899
-2% -$1.2M 0.01% 758
2024
Q1 		$64M Sell
926,554
-9,714
-1% -$614K 0.02% 552
2023
Q4 		$66.3M Buy
936,268
+183,105
+24% +$12M 0.02% 506
2023
Q3 		$51.4M Sell
753,163
-3,625
-0.5% -$308K 0.02% 553
2023
Q2 		$71.1M Sell
756,788
-8,697
-1% -$678K 0.02% 467
2023
Q1 		$51.9M Buy
765,485
+98,250
+15% +$6.32M 0.02% 537
2022
Q4 		$33M Buy
667,235
+209,965
+46% +$8.58M 0.01% 740
2022
Q3 		$14.9M Sell
457,270
-14,127
-3% -$582K 0.01% 1218
2022
Q2 		$18.6M Sell
471,397
-114,314
-20% -$6.11M 0.01% 1091
2022
Q1 		$37.4M Buy
585,711
+27,719
+5% +$2.03M 0.01% 784
2021
Q4 		$43.4M Buy
557,992
+30,477
+6% +$2.69M 0.01% 753
2021
Q3 		$50.4M Sell
527,515
-363,378
-41% -$38.4M 0.02% 685
2021
Q2 		$111M Buy
890,893
+23,216
+3% +$2.77M 0.03% 443
2021
Q1 		$114M Sell
867,677
-190,271
-18% -$26M 0.04% 420
2020
Q4 		$140M Sell
1,057,948
-73,029
-6% -$8.83M 0.05% 351
2020
Q3 		$115M Buy
1,130,977
+45,112
+4% +$3.9M 0.04% 338
2020
Q2 		$94.4M Buy
1,085,865
+340,334
+46% +$27.2M 0.04% 379
2020
Q1 		$43.2M Sell
745,531
-297,270
-29% -$24.1M 0.02% 539
2019
Q4 		$96.4M Buy
1,042,801
+52,909
+5% +$4.65M 0.04% 420
2019
Q3 		$89.5M Sell
989,892
-44,197
-4% -$5.04M 0.04% 424
2019
Q2 		$122M Buy
+1,034,089
New +$104M 0.05% 376
2018
Q2 		– Sell
-33,671
Closed -$1.36M – 1073
2018
Q1 		$1.36M Buy
33,671
+9,827
+41% +$479K 0.01% 686
2017
Q4 		$1.25M Buy
23,844
+12,116
+103% +$647K 0.01% 690
2017
Q3 		$553K Buy
+11,728
New +$472K ﹤0.01% 888

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Nuveen's EXAS Position: Q1 2026 in Review

Nuveen sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 813,252 shares — an estimated $82.6M sold.

Nuveen first reported a position in EXAS in Q3 2017 and held it in 30 quarters. The position peaked at $140M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Nuveen reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Nuveen sold 813,252 Exact Sciences shares in Q1 2026, an estimated $82.6M.
  • Nuveen first reported a position in Exact Sciences in Q3 2017 and held it in 30 quarters.
  • Nuveen's Exact Sciences position peaked at $140M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.